HCM
DMTX

Highbridge Capital Management’s Dimension Therapeutics, Inc DMTX Stock Holding History

Highbridge Capital Management’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-20,573
Closed -$123K – 1948
2016
Q2 		$123K Buy
+20,573
New +$157K ﹤0.01% 1295

Other funds holding DMTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Highbridge Capital Management's DMTX Position: Q3 2016 in Review

Highbridge Capital Management sold out of Dimension Therapeutics, Inc (DMTX) in Q3 2016, closing a stake of 20,573 shares — an estimated $123K sold.

Highbridge Capital Management first reported a position in DMTX in Q2 2016 and held it in 1 quarter. The position peaked at $123K in Q2 2016. 54 funds tracked by Wall St. Rank hold DMTX as of Q3 2016.

  • Highbridge Capital Management reported no remaining Dimension Therapeutics, Inc position as of Q3 2016 after selling out during the quarter.
  • Highbridge Capital Management sold 20,573 Dimension Therapeutics, Inc shares in Q3 2016, an estimated $123K.
  • Highbridge Capital Management first reported a position in Dimension Therapeutics, Inc in Q2 2016 and held it in 1 quarter.
  • Highbridge Capital Management's Dimension Therapeutics, Inc position peaked at $123K in Q2 2016.
  • 54 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q3 2016.

Based on Highbridge Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.